About the PulseForge Institute
Pioneering transparent, evidence-based physiology research, cardiovascular conditioning protocols, and cellular metabolic health since 2014.
A Decade of Independent Clinical Synthesis
Founded in 2014 in Mayfair, London, by Dr. Julian Vance, MD, FRCP, PulseForge Information Services Ltd was established to address a critical gap in contemporary health publishing: the pervasive commercial distortion of human physiology and sports science.
While mainstream media frequently amplifies sensationalized, single-study headlines and commercial marketing masquerades as health advice, PulseForge was created to serve as an uncompromised scientific benchmark. We distill complex biochemical pathways, randomized controlled trials, and cardiopulmonary clinical data into accessible, rigorous monographs for physicians, researchers, and proactive health practitioners.
VAT Registration: GB 392 8472 10 • Registered Office: 48 Queen Street, Mayfair, London, W1J 5EF.
The PulseForge Research Charter
Every publication, protocol, and monograph produced by our institute strictly adheres to four fundamental governance principles.
Zero Commercial Affiliations
PulseForge accepts no corporate sponsorships, product placement fees, affiliate commissions, or pharmaceutical underwriting. Our research operations are funded exclusively through institutional subscriptions and open-access educational grants.
Methodological Hierarchy
We evaluate evidence using the Oxford Centre for Evidence-Based Medicine (CEBM) hierarchy. Clinical conclusions require corroboration across multiple high-powered human randomized trials; in vitro and animal studies are explicitly flagged as mechanistic hypotheses only.
Dual-Clinician Peer Review
Prior to publication, each clinical monograph is independently audited by at least two medical specialists with active clinical registrations (GMC or international equivalent), ensuring clinical accuracy and patient safety.
Transparent Living Corrections
Scientific consensus evolves. When new landmark trials supersede prior recommendations, our monographs are revised immediately with an explicit, public changelog detailing the new scientific rationale.
Editorial & Medical Advisory Board
Distinguished clinicians and academic researchers guiding our research priorities and peer-review rigor.
Dr. Julian Vance, MD, FRCP
Founder & Editor-in-ChiefFellow of the Royal College of Physicians with 22+ years in internal medicine and metabolic cardiology. Former clinical lecturer at King's College London.
Dr. Elena Rostova, PhD
Head of Molecular BiochemistryDoctorate in Molecular Physiology from the University of Oxford. Specialist in mitochondrial electron transport chain efficiency, sirtuins, and NAD+ precursors.
Dr. Marcus Thorne, MBChB, MSc
Director of Exercise PhysiologySpecialist in Sports Medicine and Preventive Cardiology. Has served as physiologist for elite endurance athletes and national sports institutes across Europe.
Our 5-Stage Monograph Review Pipeline
From initial literature extraction to post-publication surveillance, our review workflow ensures institutional quality.
Literature Indexing
Automated & manual retrieval of clinical trials from PubMed, MEDLINE, and Cochrane Central databases matching key physiological endpoints.
Statistical Audit
Rigorous verification of p-values, confidence intervals, sample power calculations, and risk-of-bias assessments (Cochrane RoB 2 tool).
Clinical Drafting
Translating biochemical mechanism into precise clinical application protocols, contraindication tables, and dosage ranges.
Dual Peer Review
Two independent board members blind-review the monograph for safety, nuance, accuracy, and clear patient disclaimers.
Living Publication
Release to public and institutional subscribers with permanent DOI indexing, citation backlinks, and annual re-audit.
Editorial Submissions
Qualified clinicians and researchers are invited to submit papers or apply for peer-reviewer accreditation.
Apply to Advisory Board →